Bayer EBIT 2010-2024 | BAYRY

Bayer EBIT for the quarter ending September 30, 2024 was $-4.203B, a 7.44% increase year-over-year.

  • Bayer 2023 EBIT was 0.662B, a 91.03% decline from 2022.
  • Bayer 2022 EBIT was 7.388B, a 86.24% increase from 2021.
  • Bayer 2021 EBIT was 3.967B, a 121.48% decline from 2020.

EBIT can be defined as earnings before interest and taxes.

Bayer EBIT 2010-2024 | BAYRY

  • Bayer 2023 EBIT was 0.662B, a 91.03% decline from 2022.
  • Bayer 2022 EBIT was 7.388B, a 86.24% increase from 2021.
  • Bayer 2021 EBIT was 3.967B, a 121.48% decline from 2020.

EBIT can be defined as earnings before interest and taxes.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$759.4B
Novo Nordisk (NVO)$387.1B
Johnson & Johnson (JNJ)$342B
AbbVie (ABBV)$309.5B
Merck (MRK)$251.1B
AstraZeneca (AZN)$207.8B
Novartis AG (NVS)$202.5B
Pfizer (PFE)$151.4B
Sanofi (SNY)$123.7B
Innoviva (INVA)$1.1B